SEC Form 4 · accession 0001209191-16-149319
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daphne Quimi
Officer — SVP, Finance
Period of report
Nov 9, 2016
Accepted (ET)
Nov 10, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 9, 2016 | S | 5,688 | $8.00 | D | 24,189 | D | |
| Common stock | Nov 9, 2016 | M | 2,858 | $8.00 | A | 27,047 | D | |
| Common stock | Nov 9, 2016 | S | 2,858 | $8.00 | D | 24,189 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $2.45 | Nov 9, 2016 | M | 2,858 | D | Jan 1, 2018 | Jan 3, 2024 | Common stock | 2,858 | 30,892 | D |
Explanation of responses
- F1The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2016.
- F2The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2016.